Rutgers Cancer Institute partners with University Hospital to expand care

New Brunswick, N.J.-based Rutgers Cancer Institute will partner with Newark, N.J.-based University Hospital to expand cancer care services in Essex County, which maintains one of the highest cancer death rates in the state, according to NJBiz.com.

Advertisement

Officials said the partnership will ensure residents in the area have access to more cancer treatments, such as clinical trials typically only available at comprehensive care facilities, according to the article. Gov. Chris Christie, University Hospital CEO John Kastanis, Rutgers President Robert Barchi and other state officials announced the partnership on Sept. 20.

The program will be housed on the Rutgers Cancer Institute’s Newark campus.

“As an NCI-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey has the expertise to offer the latest treatment options and clinical trials as well as opportunities to reduce cancer incidence and improve patient outcomes,” said Bruce Haffty, interim director of Rutgers Cancer Institute of New Jersey. “Residents in the greater Newark area have a unique need for the most rigorous education, research and best care available, and this new partnership between Rutgers Cancer Institute and UniversityHospital will result in additional care options.”

More articles on transactions and valuations:
MD Anderson to affiliate with Deaconess Health System
Children’s Mercy, Olathe Medical Center partner on pediatric facility
Brookhaven Memorial Hospital Medical Center approves purchase of former nursing home facility

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.